TNF and synovial sarcoma: Administration of a neutralizing anti-TNF-α antibody during the stage prior to SS onset in NOD mice significantly improved salivary secretion, decreased the number of leukocyte foci, and reduced T and B cells numbers as well as T-bet protein level in submandibular glands, suggesting a decrease in Th1 and CTL cells infiltration [36].